UBTI and UBIT: The Hidden Tax Trap in Self-Directed IRA Alternative Investments
Here is the number that catches most self-directed IRA investors off guard. A trust hits the top 37% federal tax bracket at just $16,000 of income. Not $16 million. Sixteen thousand dollars....
July 11, 2026
Inside the $42 Billion Tax Credit Market Wall Street Investors Have Never Heard Of
According to Crux Climate's 2025 Market Intelligence Report , the market for transferable federal clean energy tax credits grew to roughly $42 billion in 2025, up from about $4 billion in 2023,...
July 11, 2026
Subscription Lines of Credit: How Sub Lines Distort Reported PE/VC Fund IRR
A six-month delay in calling capital can add close to two full percentage points to a private equity fund's reported IRR without changing a single dollar of profit. According to the Kenan...
July 11, 2026
400 Capital's $1.5B OceanFirst Deal Is the First US Mortgage SRT
A $1.5 billion pile of residential mortgages just moved risk off a New Jersey bank's books without a single loan changing hands. According to BusinessWire's July 8, 2026 announcement , 400...
July 11, 2026
Risk Parity Explained: How Bridgewater's All Weather Strategy Broke in 2022
Bridgewater Associates' All Weather fund lost roughly 22% in 2022. That's worse than its drawdown in the 2008 financial crisis, when the fund fell about 20%. According to Markov Processes...
July 11, 2026
Blue Owl's £1.3bn UK Hospital Deal: What It Signals for Net-Lease Income Investors
TL;DR: Blue Owl Capital just closed a £1.3bn (~$1.65B) acquisition of 12 acute-care hospitals from Spire Healthcare Group plc, buying the real estate out of a sale-and-leaseback structure previously...
July 10, 2026
Carbon Credit Investing for Accredited Investors: Compliance Markets, KRBN, and the Quality Split Reshaping the VCM in 2026
TL;DR: Carbon credits split into two markets that behave nothing alike. Compliance credits (EU ETS, California Cap-and-Trade, RGGI) trade on regulated exchanges and you can buy exposure through an...
July 10, 2026
Fundrise Innovation Fund (VCX) Review: A 1,500% NAV Premium You Shouldn't Buy
TL;DR: Fundrise Innovation Fund converted from a quarterly tender-offer fund into an NYSE-listed closed-end fund (ticker VCX) on March 19, 2026. Shares traded as high as roughly $315 against a net...
July 10, 2026
How to Read a Private Placement Memorandum: Red Flags Before You Wire Money
TL;DR: A private placement memorandum is not reviewed, approved, or fact-checked by the SEC before it lands in your inbox. In 2025 alone, four Reg D sponsors raised a combined $489M from investors...
July 10, 2026
SEC's Proposed Regulation Crypto: Three Exemption Pathways and the Section 11 Gap Investors Need to Know
TL;DR: The SEC is drafting a proposed rule called Regulation Crypto that would create three separate fundraising pathways for token issuers: a Startup Exemption capping raises around $5 million over...
July 10, 2026
Private Equity Secondaries Hit $226-240B in 2025: What the Discount-to-NAV Data Really Shows
TL;DR: The private equity secondary market hit a record $226 billion to $240 billion in 2025, up 41% to 48% year over year, depending on whether you trust Evercore's or Jefferies' count. Roughly half...
July 10, 2026
Pharmaceutical Royalty Investing: How Royalty Pharma Makes This Alt Asset Public
TL;DR: Royalty Pharma (NASDAQ: RPRX) is a $31.6-33.3 billion company that buys the right to a slice of future drug sales, and you can own it through any ordinary brokerage account for the price of...
July 10, 2026